Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors A. M. CarellaP. CorradiniS. Viviani Review Article 25 May 2018 Pages: 1301 - 1315
Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas: evidence from a meta-analysis Yi-shu HuangXiang ZhouZheng-tao Lv Review Article 11 May 2018 Pages: 1317 - 1325
The severe cytokine release syndrome in phase I trials of CD19-CAR-T cell therapy: a systematic review Zhen JinRufang XiangJunmin Li Review Article 15 May 2018 Pages: 1327 - 1335
Comorbidities, repeated hospitalizations, and age ≥ 80 years as indicators of anemia development in the older population Sylwia Sulimiera MichalakJoanna Rupa-MatysekLidia Gil Original Article Open access 09 April 2018 Pages: 1337 - 1347
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes Julia MontoroLaura GallurDavid Valcárcel Original Article 23 March 2018 Pages: 1349 - 1356
Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study Dong-Wook KimSusanne SausseleElisabetta Abruzzese Original Article Open access 20 March 2018 Pages: 1357 - 1367
Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study J. MascarenhasE. VirtgaymE. Moshier Original Article 03 April 2018 Pages: 1369 - 1374
Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia Xinfeng WangLina ZhangHongming Huang Original Article 13 April 2018 Pages: 1375 - 1389
BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation Jilei ZhangJinlong ShiLin Fu Original Article 25 April 2018 Pages: 1391 - 1397
IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCT Xiao-hui ZhangXin ZhaoXiao-jun Huang Original Article 22 March 2018 Pages: 1399 - 1406
Temporal trajectory of quality of life and its predictors in recipients of hematopoietic stem cell transplantation Ryul KimKyung-Lak SonInho Kim Original Article 03 April 2018 Pages: 1407 - 1415
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia Jonas PaludoJithma P. AbeykoonPrashant Kapoor Original Article 03 April 2018 Pages: 1417 - 1425
Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma Jinhyun ChoSeok Jin KimWon Seog Kim Original Article 08 April 2018 Pages: 1427 - 1436
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis Jung Yong HongDok Hyun YoonYoung Rok Do Original Article 04 April 2018 Pages: 1437 - 1443
Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma Satoshi YamasakiDai ChiharaRitsuro Suzuki Original Article 02 April 2018 Pages: 1445 - 1452
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients Verónica González-CalleAbigail SlackRafael Fonseca Original Article 06 April 2018 Pages: 1453 - 1462
Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis Benedikt W. PelzerMarina Arendton behalf of the Heinz Nixdorf Recall Study Investigative Group Original Article 09 April 2018 Pages: 1463 - 1469
Necrobiotic xanthogranuloma: a 30-year single-center experience Talal HilalDavid J. DiCaudoCraig B. Reeder Original Article 22 March 2018 Pages: 1471 - 1479
Clinical impact of underweight status at diagnosis on elderly patients with acute myeloid leukemia: a retrospective study of JALSG GML200 Kaito HaradaNoriko DokiKazuteru Ohashi Letter to the Editor 01 March 2018 Pages: 1481 - 1483
Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: a case report Andrea CastelliM. L. Mosca-SiezA. Conconi Letter to the Editor 29 March 2018 Pages: 1485 - 1486
Major response of PNH to an AML chemotherapy protocol Wolfgang FürederWolfgang R. SperrPeter Valent Letter to the Editor 22 March 2018 Pages: 1487 - 1488
Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma Tomonori NakazatoSatoshi TakanashiTakehiko Mori Letter to the Editor 17 February 2018 Pages: 1489 - 1491
Late-onset hemophagocytic lymphohistiocytosis with varicella zoster virus and Epstein-Barr virus co-infection after umbilical cord blood transplantation Koya OnoKen MurataShintaro Shiobara Letter to the Editor 22 March 2018 Pages: 1493 - 1495
Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae Reinhard MarksMonika EngelhardtGeorg W. Herget Letter to the Editor 25 March 2018 Pages: 1497 - 1500
Large granular lymphocytic leukemia-associated peripheral neuropathy Neeraj Y SainiVenu Bathini Letter to the Editor 22 March 2018 Pages: 1501 - 1504
A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray Jihye HaBorahm KimJong rak Choi Letter to the Editor 08 March 2018 Pages: 1505 - 1507
Isolated Richter’s syndrome of the brain: diagnosis in the eye of the beholder Ana Luísa PintoGisela FerreiraMaria Letícia Ribeiro Letter to the Editor 08 April 2018 Pages: 1509 - 1511
Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review Megumi YasunagaKazuki TaokaMineo Kurokawa Letter to the Editor 13 March 2018 Pages: 1513 - 1515
Eltrombopag as initial monotherapy for severe aplastic anemia—a case report George M. RodgersJeffrey A. Gilreath Letter to the Editor 20 March 2018 Pages: 1517 - 1518
